Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
QNRX
QNRX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
QNRX News
Quoin Pharmaceuticals Q4 Earnings Beat Expectations
4d ago
seekingalpha
Biotech Landscape Update: Regulatory Approvals and Mergers
3d ago
NASDAQ.COM
Quoin Pharmaceuticals Provides Clinical Update on QRX003
4d ago
NASDAQ.COM
Quoin Pharmaceuticals Shares Surge 20% on FDA Feedback for QRX003
5d ago
stocktwits
QNRX Shares Jump 20% in Pre-Market Trading – FDA's Comments on Netherton Syndrome Treatment?
5d ago
stocktwits
Quoin Pharmaceuticals Advances FDA Approval Process for QRX003
5d ago
Newsfilter
Quoin Pharmaceuticals Advances NETHERTON NOW Awareness Campaign
Feb 26 2026
Newsfilter
Quoin Pharmaceuticals Files for Breakthrough Designation for QRX003, Potential First Treatment for Netherton Syndrome
Jan 20 2026
Globenewswire
Quoin Pharmaceuticals Stock Rises 21% Following Topical Rapamycin Achievement
Nov 11 2025
NASDAQ.COM
US Stocks Show Varied Performance; Sea Shares Rise Following Q3 Earnings Report
Nov 11 2025
Benzinga
Quoin Pharmaceuticals Receives Orphan Drug Designation from U.S. FDA for QRX003 in Netherton Syndrome
Oct 21 2025
Newsfilter
What’s Driving Quoin Pharmaceuticals' Pre-market Surge?
Oct 21 2025
NASDAQ.COM
Reasons Behind the Surge in Quoin Pharmaceuticals Stock (QNRX) Today
Oct 10 2025
TipRanks
Quoin Pharmaceuticals Unveils Private Placement Funding Opportunity of Up to $104.5 Million
Oct 10 2025
Newsfilter
Quoin Pharmaceuticals Reveals Private Placement Financing of Up to $104.5 Million
Oct 10 2025
SeekingAlpha
New Fortress Energy Shares Surge 41%; Check Out 20 Stocks Making Moves in Premarket Trading
Sep 17 2025
Benzinga
Show More News
